Acetazolamide

Active ingredient description

Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
S01EC01
Acetazolamide
S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC01

Medicines

Acetazolamide is the active ingredient of these drugs:

Drug
Countries
ACEMIT

Germany

DIACARB

Lithuania

DIAMOX

Australia Austria Brazil France Ireland

EDEMOX

Spain

GLAUPAX

Germany

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
DIAMOX SR Capsule
Summary of product characteristics (SPC)
UK
DIAMOX Sodium Powder for solution for injection
Summary of product characteristics (SPC)
UK
DIAMOX Tablet
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

O3FX965V0I - ACETAZOLAMIDE

CAS registry number

59-66-5 - acetazolamide

SNOMED-CT

372709008 - Acetazolamide (substance)

Next: Usage